- North America
- Service category
- Clinical development and testing, clinical CRO
Your company? Get access to this profile.
The company is a specialty Contract Research Organization which dedicates its expertise and technology to the evaluation of the cardiac safety of new drugs at an early stage of their development, by using validated and highly predictive models. Recognized for the quality and the on-time delivery of its IND enabling studies, IPS Therapeutique addresses the particular needs of start-up and mature biopharmaceutical companies which are looking for fast and cost-effective solutions to assess the QT Prolongation and the arrhythmogenic liability of their new compound(s) during preclinical development.
Pictures of this company
You might also be interested in
Sourcing this company's services?Send inquiry anonymously »